A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
Abroad (travel likely)RecruitingPHASE2
Conditions
Primary Sclerosing Cholangitis (PSC)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of California Davis, Sacramento, California, United States
Contact: Principal Investigator (Christopher Bowlus, MD)UCHealth University of Colorado Hospital, Aurora, Colorado, United States
Contact: Principal Investigator (Lisa Forman, MD)University Of Iowa Hospitals And Clinics, Iowa City, Iowa, United States
Contact: Principal Investigator (Alan Gunderson, MD)Mercy Medical Center, Baltimore, Maryland, United States
Contact: Principal Investigator (Paul Thuluvath, MD)Mayo Clinic, Rochester, Minnesota, United States
Contact: Principal Investigator (John Eton, MD)The Vanderbilt Clinic, Nashville, Tennessee, United States
Contact: Principal Investigator (Manhal Izzy, MD)Liver institute Northwest, Seattle, Washington, United States
Contact: Principal Investigator (Kris Kowdley, MD)